Literature DB >> 21053061

Inflammation alters angiotensin converting enzymes (ACE and ACE-2) balance in rat heart.

Sherif Hanafy1, Mahtab Tavasoli, Fakhreddin Jamali.   

Abstract

Angiotensin converting enzymes (ACE) and more recently discovered ACE-2 are important proteins involved in the renin-angiotensin system. The balance between ACE and ACE-2 is important for the regulation of blood pressure and electrolyte homeostasis. Inflammatory diseases like rheumatoid arthritis are associated with increased risk for cardiovascular complications. We studied the effect of inflammation on the expression levels of ACE and ACE-2 in two groups (n = 4/group) of adjuvant arthritis (AA) and healthy (control) rats. The AA group received 0.2 ml of 50 mg ml(-1) of Mycobacterium butyricum suspended in squalene into the tail base. On day 12, rats were euthanized and their organs (hearts, liver, kidney, and intestine) were excised. The mRNA of ACE and ACE-2 were determined by real-time polymerase chain reaction. ACE and ACE-2 protein expression in rat heart was determined by Western blot. Inflammation resulted in 80% reduction of ACE-2 gene expression in rat heart. ACE-2/ACE expression ratio was significantly reduced from 0.7 ± 0.4 in control rats to 0.07 ± 0.09 in AA. Similarly, ACE-2/ACE protein expression ratio was also disrupted with a significant reduction in AA animals (6.7 ± 4.8 vs. 0.9 ± 05 in control and AA, respectively). ACE-2 has been found to provide negative feedback of renin-angiotensin system and protection of the heart and kidneys. Disruption of the balance between ACE and ACE-2 observed in inflammation may be, at least in part, involved in the cardiovascular complications seen in patients with inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21053061     DOI: 10.1007/s10753-010-9269-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

1.  mRNA and 18S-RNA coapplication-reverse transcription for quantitative gene expression analysis.

Authors:  Li-ji Zhu; Scott W Altmann
Journal:  Anal Biochem       Date:  2005-10-01       Impact factor: 3.365

2.  Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat.

Authors:  Guillaume Rivière; Annie Michaud; Christophe Breton; Gilles VanCamp; Christine Laborie; Mihaela Enache; Jean Lesage; Sylvie Deloof; Pierre Corvol; Didier Vieau
Journal:  Hypertension       Date:  2005-10-03       Impact factor: 10.190

3.  Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.

Authors:  Takeo Sakuta; Yoshitaka Morita; Minoru Satoh; David A Fox; Naoki Kashihara
Journal:  Arthritis Rheum       Date:  2010-05

4.  Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis.

Authors:  P R Mayo; K Skeith; A S Russell; F Jamali
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

Review 5.  Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.

Authors:  Nigel J Dagenais; Fakhreddin Jamali
Journal:  Pharmacotherapy       Date:  2005-09       Impact factor: 4.705

6.  Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.

Authors:  S Wållberg-Jonsson; H Johansson; M L Ohman; S Rantapää-Dahlqvist
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

7.  Angiotensin receptors and angiotensin I-converting enzyme in rat intestine.

Authors:  K A Duggan; F A Mendelsohn; N R Levens
Journal:  Am J Physiol       Date:  1989-10

8.  Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.

Authors:  Noriko Daneshtalab; Richard Z Lewanczuk; Anthony Russell; Fakhreddin Jamali
Journal:  J Clin Pharmacol       Date:  2004-03       Impact factor: 3.126

9.  Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers.

Authors:  S Hanafy; N J Dagenais; W F Dryden; F Jamali
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

10.  Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents.

Authors:  Florian Gembardt; Anja Sterner-Kock; Hans Imboden; Matthias Spalteholz; Franziska Reibitz; Heinz-Peter Schultheiss; Wolf-Eberhard Siems; Thomas Walther
Journal:  Peptides       Date:  2005-02-16       Impact factor: 3.750

View more
  8 in total

1.  Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin-angiotensin system in experimental arthritis.

Authors:  Waheed Asghar; Ali Aghazadeh-Habashi; Fakhreddin Jamali
Journal:  Inflammopharmacology       Date:  2017-04-07       Impact factor: 4.473

2.  Angiotensin-(1-7) attenuates collagen-induced arthritis via inhibiting oxidative stress in rats.

Authors:  Juan Liu; Yan Liu; Wenyou Pan; Yongsheng Li
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

3.  A snapshot of the Ixodes scapularis degradome.

Authors:  Albert Mulenga; Kelly Erikson
Journal:  Gene       Date:  2011-04-28       Impact factor: 3.688

Review 4.  Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure.

Authors:  Ryousuke Satou; Harrison Penrose; L Gabriel Navar
Journal:  Curr Hypertens Rep       Date:  2018-10-05       Impact factor: 5.369

5.  Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.

Authors:  Victor Gustavo Balera Brito; Mariana Sousa Patrocinio; Maria Carolina Linjardi de Sousa; Ayná Emanuelli Alves Barreto; Sabrina Cruz Tfaile Frasnelli; Vanessa Soares Lara; Carlos Ferreira Santos; Sandra Helena Penha Oliveira
Journal:  Front Pharmacol       Date:  2020-11-11       Impact factor: 5.810

6.  Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice.

Authors:  Sonja Schötterl; Stephan M Huber; Hans Lentzen; Michel Mittelbronn; Ulrike Naumann
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-27       Impact factor: 2.629

7.  The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.

Authors:  I-Chen Chen; Jao-Yu Lin; Yi-Ching Liu; Chee-Yin Chai; Jwu-Lai Yeh; Jong-Hau Hsu; Bin-Nan Wu; Zen-Kong Dai
Journal:  Int J Med Sci       Date:  2020-09-16       Impact factor: 3.738

Review 8.  Berries and Their Polyphenols as a Potential Therapy for Coronary Microvascular Dysfunction: A Mini-Review.

Authors:  Rami S Najjar; Arielle M Schwartz; Brett J Wong; Puja K Mehta; Rafaela G Feresin
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.